Speech-Language Pathologists in Maryland - Medicare Status, Address, Contact

4261 Speech-Language Pathologists found. Showing 41 - 60

Jennifer Ryan, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Road, Annapolis, MD 21401 Phone: 410-222-5000

Karla Elam, MS, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Amy Russ Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Rebecca N Winans Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

April Queen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 443-222-5000

S.p.e.a.k., Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1131 Ramblewood Dr, Annapolis, MD 21409 Phone: 410-349-0332    Fax: 410-349-8452

Erika Shultz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Julie Hazelton Rankin, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Megan Emily Grossman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Sara Kathryn Dexter, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Ms. Robyn Healy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Brittany D Chelchowski Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Chelsea Elizabeth Vonsas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Genna Katrina Arnell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 180 Green St, Annapolis, MD 21401 Phone: 410-222-1600

Douglas Rubenstein Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Myra Sydnor Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411    Fax: 410-571-6415

Heather Lynne Gapen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Melissa Ramsey Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Saundra James-crawley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Erica Lynn Prentice, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Defense Hwy, Annapolis, MD 21401 Phone: 410-573-1064

News Archive

Separate studies produce conflicting results on race and gender disparities in U.S. health system

Two newly released studies in the U.S. have to some extent come to conflicting results. According to one study, by researchers at Emory University, attempts over the last decade to address race and gender disparities in the treatment of U.S. patients hospitalized for heart attacks, still in some respects raise cause for concern.

Trius receives patent protection for torezolid phosphate in the U.S.

Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).

Researchers identify chemical pathway associated with seizures, shorter survival in patients with malignant glioma

Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.

COVID-19 has been reported to trigger Guillain–Barré syndrome

Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barré Syndrome - a rare disorder where the body's immune system attacks nerves and can lead to respiratory failure and death.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3(current)
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »